Vasamed, Inc.
VSMD · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.7% | 1.5% | -20.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30.4% | 11.3% | 12.2% | 18.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -155% | -177% | -247.2% | -161.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -334.5% | -362.5% | -270.7% | -170.6% |
| EPS Diluted | -0.45 | -0.44 | -0.32 | -0.26 |
| % Growth | -2.3% | -37.5% | -23.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |